Displaying items by tag:

UAB received over $325 million in research funding from the National Institutes of Health (NIH) in 2020.

The School of Medicine holds a remarkable 193 endowed chairs and 103 endowed professorship positions. These honors contribute to recruitment and retention of premier teachers, clinicians, and researchers. This year, 23 faculty members received endowments.
Five faculty projects were recently funded through an AMC21 initiative giving NIH-funded investigators incentive to submit a second R01.
Physicians at UAB share tips on men’s health and how it affects heart health, sexual function and memory and decreases cancer risk.
Soroush Rais-Bahrami, M.D., discusses the importance of prostate cancer screening and what families should know about loved ones who have been diagnosed.
Urologist Dean Assimos, M.D., has led the development of extensive guidelines of surgical management of kidney stones.
Prostate cancer physicians look to provide personalized medicine to prostate cancer patients with a new medical device.
David Joseph, M.D., lauded by UAB, Children’s of Alabama at the American Academy of Pediatrics for Excellence.
The UAB-HudsonAlpha Center for Genomic Medicine has awarded its first pilot grants to teams of researchers from the two institutions to pursue projects in cancer and cardiac disease.
The prostate-specific antigen, or PSA, test has limitations, but the new Prostate Health Index can offer an exact percentage of prostate cancer risk.
Page 1 of 2